Key Takeaways
- Avery Dennison Corp. reported first-quarter 2026 adjusted earnings per share of $2.15, falling short of analyst consensus estimates of $2.25.
- Shares of $AVY declined 7.2% to $198.50 in midday trading following the earnings release on April 24, 2026.
- The company's lowered full-year 2026 adjusted EPS guidance, now $8.60-$9.00 from $9.20-$9.60, shifts investor focus to long-term growth strategies amidst persistent macro challenges.
- Organic sales growth of 3.5% was offset by a 75 basis point decline in gross margin to 29.8%, signaling continued cost pressures.
- The performance underscores the broader challenge for industrial manufacturers balancing innovation with cost control in a volatile global economy.
Avery Dennison Navigates Growth Amidst Macro Headwinds
Avery Dennison Corp. ($AVY) reported mixed financial results for the first quarter of fiscal year 2026, with moderate organic sales growth overshadowed by margin compression and a cautious outlook that prompted a significant revision to its full-year earnings guidance. The global materials science and manufacturing company announced adjusted earnings per share (EPS) of $2.15 for the quarter ended March 30, 2026, missing the Bloomberg consensus estimate of $2.25 per share. Total net sales for the quarter reached $2.23 billion, reflecting a 3.5% organic increase year-over-year, primarily driven by pricing actions and modest volume improvements in certain segments.
The market reacted swiftly to the news, with $AVY shares falling 7.2% to $198.50 by 1:30 PM ET on April 24, 2026. This decline occurred on trading volumes nearly 150% higher than the 30-day average, indicating strong investor reaction to the updated guidance and margin performance. The revised full-year 2026 adjusted EPS projection now stands between $8.60 and $9.00, a notable reduction from the previous range of $9.20 to $9.60, citing ongoing raw material cost volatility and softer demand in some end markets.
Market Impact
Avery Dennison's stock plunge marked its largest single-day percentage decline since October 2024, when the company issued a similar cautious outlook amidst supply chain disruptions. The $AVY shares breached the $200 support level, a psychological threshold that had held firm since early March 2026, indicating a significant shift in investor sentiment. The company's market capitalization shed approximately $1.1 billion following the announcement, settling at roughly $16.5 billion.
The downward revision in guidance weighed on the broader industrial materials sector, with peers like $PKG (Packaging Corporation of America) and $SEE (Sealed Air Corp.) experiencing modest declines of 1.5% and 0.9% respectively, though not as severe as $AVY. This suggests a sector-specific concern about input costs and demand elasticity, rather than a broad market sell-off. The relative strength of the U.S. dollar against key currencies also contributed to a 1.2% headwind on reported sales, further complicating the revenue picture for $AVY's international operations, which constitute over 70% of its total revenue.
What Analysts Are Saying
JPMorgan Chase & Co. analysts, led by Michael Roxbury, downgraded $AVY from "Overweight" to "Neutral" and cut their price target to $210 from $240 following the report. "While Avery Dennison continues to demonstrate resilience in high-value segments like intelligent labels, persistent gross margin pressure β down 75 basis points year-over-year to 29.8% β and the magnitude of the full-year EPS guidance cut are difficult to ignore," Roxbury noted in a client communication. "The company's strategic pivot towards RFID and sustainable solutions is sound, but the near-term macro environment is proving more challenging than anticipated, impacting profitability."
Conversely, analysts at BofA Securities maintained their "Buy" rating, albeit with a reduced price target of $235 from $255, emphasizing the long-term potential. "Despite the current headwinds, Avery Dennison's robust innovation pipeline, particularly in its Materials Group and Solutions Group, positions it well for future growth," stated BofA analyst Sarah Chen. "The increased investment in R&D, up 8% year-over-year to $78 million in Q1, supports the company's shift towards higher-margin, differentiated products, which should yield significant returns once the inflationary pressures subside."
Citigroup Inc. analysts highlighted the disparity between organic sales growth and operating income. "Operating income declined 5% year-over-year to $234 million, reflecting a 70 basis point contraction in operating margin to 10.5%," a Citi research note indicated. "This suggests that while the company is managing to grow the top line, it is struggling to translate that into proportional earnings growth due to elevated operational costs and strategic reinvestments. The market's reaction is largely a reflection of this profitability squeeze."
What to Watch
Investors will closely monitor Avery Dennison's ability to execute its growth mix strategies, particularly the expansion of its high-value intelligent labels portfolio and sustainable solutions, which are critical for margin expansion. The company's investor day, tentatively scheduled for late Q3 2026, will likely offer more detailed insights into these initiatives and their projected financial impact. Continued progress in reducing input costs, especially for polymers and specialty chemicals, will be crucial for gross margin recovery; any significant easing of these costs could provide an upside surprise.
Key technical levels to watch for $AVY shares include immediate support at $195, a level tested in late 2025, and then $188. On the upside, reclaiming the $200 psychological mark and then $210, a previous resistance level, would signal a potential stabilization. The company's Q2 2026 earnings call, expected in late July, will provide the next update on the trajectory of its revised guidance and the effectiveness of its cost management efforts. Any further deterioration in global industrial production or consumer demand for packaged goods could exacerbate current challenges, posing a risk to the revised outlook.


